ORIC PHARMACEUTICALS, INC. Capital Expenditures
ORIC PHARMACEUTICALS, INC. (ORIC) reported Capital Expenditures of $358.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $356.00K, a 465.08% increase year-over-year.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $2.00K, a 99.48% decline year-over-year.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $227.00K, a 3.65% increase year-over-year.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $35.00K, a 91.63% decline year-over-year.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $712.00K, a 40.07% decline from fiscal 2024.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $1.19M, a 39.93% increase from fiscal 2023.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $849.00K, a 59.14% decline from fiscal 2022.
- ORIC PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $2.08M, a 121.30% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $358.00K 10-Q · filed 2026-08-03 | $585.00K derived: sum of 3 quarters · filed 2026-08-03 | $620.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $2.00K 10-Q · filed 2026-05-04 | $229.00K derived: sum of 2 quarters · filed 2026-05-04 | $264.00K derived: sum of 3 quarters · filed 2026-05-04 | $327.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $262.00K derived: sum of 2 quarters · filed 2026-02-23 | $325.00K derived: sum of 3 quarters · filed 2026-08-03 | $712.00K 10-K · filed 2026-02-23 |
| 2025-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $98.00K derived: sum of 2 quarters · filed 2026-08-03 | $485.00K 10-Q · filed 2025-11-13 | $704.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $450.00K 10-Q · filed 2026-08-03 | $669.00K derived: sum of 3 quarters · filed 2026-08-03 | $1.09M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $387.00K 10-Q · filed 2026-05-04 | $606.00K derived: sum of 2 quarters · filed 2026-05-04 | $1.02M derived: sum of 3 quarters · filed 2026-05-04 | $1.36M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $637.00K derived: sum of 2 quarters · filed 2026-02-23 | $970.00K derived: sum of 3 quarters · filed 2026-02-23 | $1.19M 10-K · filed 2026-02-23 |
| 2024-09-30 | $418.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $751.00K derived: sum of 2 quarters · filed 2025-11-13 | $969.00K 10-Q · filed 2025-11-13 | $1.03M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $551.00K 10-Q · filed 2025-08-12 | $608.00K derived: sum of 3 quarters · filed 2025-08-12 | $685.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $218.00K 10-Q · filed 2025-05-05 | $275.00K derived: sum of 2 quarters · filed 2025-05-05 | $352.00K derived: sum of 3 quarters · filed 2025-05-05 | $757.00K derived: sum of 4 quarters · filed 2025-05-05 |
| 2023-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $134.00K derived: sum of 2 quarters · filed 2025-02-18 | $539.00K derived: sum of 3 quarters · filed 2025-02-18 | $849.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $482.00K derived: sum of 2 quarters · filed 2024-11-12 | $792.00K 10-Q · filed 2024-11-12 | $1.08M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $405.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $715.00K 10-Q · filed 2024-08-12 | $1.00M derived: sum of 3 quarters · filed 2024-08-12 | $1.40M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $310.00K 10-Q · filed 2024-05-06 | $597.00K derived: sum of 2 quarters · filed 2024-05-06 | $998.00K derived: sum of 3 quarters · filed 2024-05-06 | $1.67M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $688.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.35M derived: sum of 3 quarters · filed 2024-03-11 | $2.08M 10-K · filed 2024-03-11 |
| 2022-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.07M derived: sum of 2 quarters · filed 2023-11-06 | $1.79M 10-Q · filed 2023-11-06 | $2.18M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $667.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.39M 10-Q · filed 2023-08-10 | $1.78M derived: sum of 3 quarters · filed 2023-08-10 | $2.01M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $723.00K 10-Q · filed 2023-05-08 | $1.11M derived: sum of 2 quarters · filed 2023-05-08 | $1.34M derived: sum of 3 quarters · filed 2023-05-08 | $1.48M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $622.00K derived: sum of 2 quarters · filed 2023-03-16 | $757.00K derived: sum of 3 quarters · filed 2023-03-16 | $939.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $368.00K derived: sum of 2 quarters · filed 2022-11-07 | $550.00K 10-Q · filed 2022-11-07 | $961.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $317.00K 10-Q · filed 2022-08-11 | $728.00K derived: sum of 3 quarters · filed 2022-08-11 | $778.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $182.00K 10-Q · filed 2022-05-09 | $593.00K derived: sum of 2 quarters · filed 2022-05-09 | $643.00K derived: sum of 3 quarters · filed 2022-05-09 | $845.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $461.00K derived: sum of 2 quarters · filed 2022-03-21 | $663.00K derived: sum of 3 quarters · filed 2022-03-21 | $667.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $252.00K derived: sum of 2 quarters · filed 2021-11-08 | $256.00K 10-Q · filed 2021-11-08 | $312.00K derived: sum of 4 quarters · filed 2022-03-21 |
| 2020-06-30 | $202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $206.00K 10-Q · filed 2021-08-10 | $262.00K derived: sum of 3 quarters · filed 2022-03-21 | $481.00K derived: sum of 4 quarters · filed 2022-03-21 |
| 2020-03-31 | $4.00K 10-Q · filed 2021-05-06 | $60.00K derived: sum of 2 quarters · filed 2022-03-21 | $279.00K derived: sum of 3 quarters · filed 2022-03-21 | $672.00K derived: sum of 4 quarters · filed 2022-03-21 |
| 2019-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $275.00K derived: sum of 2 quarters · filed 2022-03-21 | $668.00K derived: sum of 3 quarters · filed 2022-03-21 | $768.00K 10-K · filed 2022-03-21 |
| 2019-09-30 | $219.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $612.00K derived: sum of 2 quarters · filed 2020-11-05 | $712.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $493.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $100.00K 10-Q · filed 2020-05-20 | |||
| 2018-12-31 | $525.00K 10-K · filed 2021-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |